EnWave Receives Favorable PCT Review for Key Intellectual Property

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 10, 2012) - EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") announced today that the Company has received a favorable review from the Patent Cooperation Treaty ("PCT") Examiner for its Radiant Energy Vacuum ("REV") patent application that protects the technological fundamentals used in both the quantaREV™ and continuous powderREV™ designs. More specifically, this patent application, if successfully accepted in the regional filing jurisdictions, will help protect EnWave's engineering design modifications that allow for a highly scalable and controllable dehydration method with the ultimate target of tonnage throughput per hour. EnWave will now continue the process by filing this patent in major market and population jurisdictions around the world to ensure maximum protection over the innovation.

"Protecting our technology is of paramount importance as our business model is focused on leveraging our valuable intellectual property," stated Dr. Tim Durance, Chairman and Co-CEO, EnWave Corporation. "This positive result provides additional validation to the novel and inventive elements of quantaREV™ for large-scale food drying and powderREV™ for continuous accelerated freeze-drying of pharmaceuticals and other high value products."

EnWave's business model allows collaborators to obtain exclusive testing rights and royalty-bearing licenses for specific products using the Company's proprietary REV dehydration technologies. Patents and knowhow are the basis on which the Company is able to grant exclusivity of use to many of its multinational partners who through research and collaboration agreements are evaluating opportunities for commercial use of the technology.

EnWave holds an expanding intellectual property portfolio designed to protect its technology and knowledge base. The Company's patented technology combines microwave energy with vacuum pressure to control the temperature at which liquids boil and subsequently evaporate. This form of liquid evaporation is a major advancement in the dehydration of food and biological materials. REV technology is currently being developed to replace freeze drying and compete directly with spray and air drying.

About EnWave

EnWave Corporation is a Vancouver-based industrial technology company developing commercial applications for its proprietary Radiant Energy Vacuum (REV) dehydration technology. The company has recently licensed REV technology to Milne Fruit Products Inc, its first major U.S. customer, to support a launch of healthy berry snacks and powders across most major markets in North America. In addition, EnWave has entered a wide range of research and collaboration agreements with an expanding list of multinational partners, including Nestlé, Kellogg's, Grupo Bimbo, Grimmway Farms, Ocean Spray Cranberries, Hormel, Bonduelle and Merck. EnWave is introducing REV as a new dehydration standard in the food and biological material sectors: potentially faster and cheaper than freeze drying, with better end product quality than air drying or spray drying.

EnWave currently has six REV platforms: commercial-scale nutraREV™ and MIVAP™ are used in the food industry to dry fruits, vegetables, meat, herbs and seafood quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour. The Company is also developing powderREV™ for bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes; quantaREV™ for continuous, high-volume low-temperature drying of pastes, gels, liquids, or particulates; and bioREV™ and freezeREV™ as new methods to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. There is no guarantee that the Company's REV technology can or will improve processes in the target industry; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology. All figures comparing REV technologies to freeze drying or other dehydration technologies are provided as examples of data obtained through the Company's own scientific and testing programs; each product must be tested individually to determine the benefits of using REV.